Search results
The Lancet reportedly pays for peer review "sometimes". Reviewers for journals published by the American Economic Association earn $100 for each "timely" review. Zentralblatt MATH (zbMATH) pays 2.56 EUR per review, although this is for post-publication reviews that are then published.
22 lut 2021 · COV003 is a single-blinded, multi-centre, randomised, controlled Phase III trial assessing the safety, efficacy, and immunogenicity of AstraZeneca’s COVID-19 vaccine in 10,300 participants in Brazil.
We identified 100 published peer-reviewed articles relevant to the Oxford–AstraZeneca vaccine or the ChAdOx technology (online supplemental files 1 and 2). Publication dates ranged from January 2002 to November 2020.
Find a clinical trial. This site is part of AstraZeneca`s commitment to provide patients, their relatives, caregivers, doctors, researchers and the public with information about AstraZeneca clinical trials, which includes trials sponsored by a member of the AstraZeneca Group of Companies.
10 gru 2020 · The Oxford/AstraZeneca vaccine this week became the first major COVID vaccine candidate to have efficacy results from phase 3 trials published in a peer-reviewed journal. The vaccine,...
25 mar 2021 · AstraZeneca says it plans to file for emergency-use authorization for the vaccine from the US Food and Drug Administration (FDA), and to submit the analysis of the trial for peer review and...
To fund the deal, AstraZeneca issued a $3.5 billion equity placement, a highly unusual mechanism to fund a pharma licensing transaction. The move paid off, as today T-DXd showcases what next...
